NCT04067570View on ClinicalTrials.gov

Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

October 31, 2030

Study Completion Date

October 31, 2030

Conditions
SBRTRadical Prostatectomy
Interventions
RADIATION

SBRT

Stereotactic body radiation therapy, or SBRT, is a cancer treatment that delivers extremely precise, very intense doses of radiation to cancer cells while minimizing damage to healthy tissue

Trial Locations (1)

M4N3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT04067570 - Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer | Biotech Hunter | Biotech Hunter